Arjo AB (publ)

LSE:0HQ8 Stock Report

Market Cap: SEK 10.1b

Arjo Valuation

Is 0HQ8 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0HQ8 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
SEK 89.45
Fair Value
58.4% undervalued intrinsic discount
6
Number of Analysts

Below Fair Value: 0HQ8 (SEK37.23) is trading below our estimate of fair value (SEK89.45)

Significantly Below Fair Value: 0HQ8 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0HQ8?

Key metric: As 0HQ8 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0HQ8. This is calculated by dividing 0HQ8's market cap by their current earnings.
What is 0HQ8's PE Ratio?
PE Ratio20.1x
EarningsSEK 505.00m
Market CapSEK 10.15b

Price to Earnings Ratio vs Peers

How does 0HQ8's PE Ratio compare to its peers?

The above table shows the PE ratio for 0HQ8 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average31.6x
NIOX NIOX Group
22.9x18.4%UK£253.1m
EKF EKF Diagnostics Holdings
24.4xn/aUK£116.6m
SN. Smith & Nephew
36.2x22.6%UK£9.0b
AMS Advanced Medical Solutions Group
42.8x20.8%UK£472.8m
0HQ8 Arjo
20.1x23.7%SEK 10.1b

Price-To-Earnings vs Peers: 0HQ8 is good value based on its Price-To-Earnings Ratio (20.1x) compared to the peer average (31.6x).

Price to Earnings Ratio vs Industry

How does 0HQ8's PE Ratio compare vs other companies in the European Medical Equipment Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0HQ8 20.1xIndustry Avg. 31.8xNo. of Companies8PE01632486480+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0HQ8 is good value based on its Price-To-Earnings Ratio (20.1x) compared to the European Medical Equipment industry average (31.8x).

Price to Earnings Ratio vs Fair Ratio

What is 0HQ8's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0HQ8 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.1x
Fair PE Ratio33.2x

Price-To-Earnings vs Fair Ratio: 0HQ8 is good value based on its Price-To-Earnings Ratio (20.1x) compared to the estimated Fair Price-To-Earnings Ratio (33.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0HQ8 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 37.23
SEK 43.17
+15.9%
13.7%SEK 55.00SEK 37.00n/a6
Jan ’26SEK 36.26
SEK 41.00
+13.1%
7.4%SEK 45.00SEK 37.00n/a5
Dec ’25SEK 34.32
SEK 41.60
+21.2%
5.8%SEK 45.00SEK 39.00n/a5
Nov ’25SEK 35.43
SEK 44.00
+24.2%
15.3%SEK 57.00SEK 39.00n/a5
Oct ’25SEK 44.34
SEK 52.60
+18.6%
9.0%SEK 58.00SEK 45.00n/a5
Sep ’25SEK 41.51
SEK 51.80
+24.8%
11.3%SEK 58.00SEK 42.00n/a5
Aug ’25SEK 40.80
SEK 51.80
+27.0%
11.3%SEK 58.00SEK 42.00n/a5
Jul ’25SEK 40.82
SEK 51.25
+25.6%
18.4%SEK 58.00SEK 35.00n/a4
Jun ’25SEK 46.02
SEK 51.25
+11.4%
18.4%SEK 58.00SEK 35.00n/a4
May ’25SEK 46.96
SEK 51.25
+9.1%
18.4%SEK 58.00SEK 35.00n/a4
Apr ’25SEK 51.31
SEK 51.60
+0.6%
17.1%SEK 60.00SEK 35.00n/a5
Mar ’25SEK 48.82
SEK 51.60
+5.7%
17.1%SEK 60.00SEK 35.00n/a5
Feb ’25SEK 49.10
SEK 50.60
+3.0%
16.6%SEK 60.00SEK 35.00n/a5
Jan ’25SEK 39.62
SEK 44.25
+11.7%
22.5%SEK 55.00SEK 30.00SEK 36.264
Dec ’24SEK 38.64
SEK 44.25
+14.5%
22.5%SEK 55.00SEK 30.00SEK 34.324
Nov ’24SEK 37.58
SEK 50.00
+33.0%
14.1%SEK 55.00SEK 40.00SEK 35.433
Oct ’24SEK 42.25
SEK 50.67
+19.9%
12.1%SEK 55.00SEK 42.00SEK 44.343
Sep ’24SEK 42.77
SEK 50.33
+17.7%
13.1%SEK 55.00SEK 41.00SEK 41.513
Aug ’24SEK 44.07
SEK 50.33
+14.2%
13.1%SEK 55.00SEK 41.00SEK 40.803
Jul ’24SEK 38.99
SEK 50.67
+30.0%
12.1%SEK 55.00SEK 42.00SEK 40.823
Jun ’24SEK 41.37
SEK 52.33
+26.5%
14.5%SEK 60.00SEK 42.00SEK 46.023
May ’24SEK 45.12
SEK 46.67
+3.4%
20.5%SEK 60.00SEK 38.00SEK 46.963
Apr ’24SEK 40.49
SEK 44.33
+9.5%
25.1%SEK 60.00SEK 35.00SEK 51.313
Mar ’24SEK 39.70
SEK 44.33
+11.7%
25.1%SEK 60.00SEK 35.00SEK 48.823
Feb ’24SEK 39.95
SEK 46.67
+16.8%
22.0%SEK 60.00SEK 35.00SEK 49.103
Jan ’24SEK 39.68
SEK 53.25
+34.2%
15.6%SEK 63.00SEK 45.00SEK 39.624
Analyst Price Target
Consensus Narrative from 6 Analysts
SEK 43.11
Fair Value
13.6% undervalued intrinsic discount
6
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 20:47
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arjo AB (publ) is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Erik CasselDanske Bank